Fortress Biotech Ownership
| FBIO Stock | USD 1.68 0.07 4.35% |
Shares in Circulation | First Issued 2010-03-31 | Previous Quarter 18.3 M | Current Value 19.7 M | Avarage Shares Outstanding 4.8 M | Quarterly Volatility 3.7 M |
Please note, institutional investors have a lot of resources and new technology at their disposal. They can put in a lot of research and financial analysis when reviewing investment options. There are many different types of institutional investors, including banks, hedge funds, insurance companies, and pension plans. One of the main advantages they have over retail investors is the fees paid for trades. As they are buying in large quantities, they can manage their cost more effectively.
Fortress |
Fortress Stock Ownership Analysis
About 21.0% of the company shares are held by company insiders. The book value of Fortress Biotech was currently reported as 0.79. The company recorded a loss per share of 27.73. Fortress Biotech had not issued any dividends in recent years. The entity had 1:15 split on the 10th of October 2023. Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Island, New York. Fortress Biotech operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 173 people. To learn more about Fortress Biotech call Lindsay Rosenwald at 781 652 4500 or check out https://www.fortressbiotech.com.Besides selling stocks to institutional investors, Fortress Biotech also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Fortress Biotech's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Fortress Biotech's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Fortress Biotech Quarterly Liabilities And Stockholders Equity |
|
About 21.0% of Fortress Biotech are currently held by insiders. Unlike Fortress Biotech's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Fortress Biotech's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Fortress Biotech's insider trades
Fortress Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Fortress Biotech is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Fortress Biotech backward and forwards among themselves. Fortress Biotech's institutional investor refers to the entity that pools money to purchase Fortress Biotech's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 78.1 K | Atria Investments Llc | 2024-09-30 | 71.5 K | 180 Wealth Advisors, Llc | 2024-09-30 | 68.3 K | Meridian Wealth Management, Llc | 2024-06-30 | 65.5 K | Millennium Management Llc | 2024-06-30 | 65.2 K | Commonwealth Equity Services Inc | 2024-06-30 | 61.7 K | Hb Wealth Management, Llc | 2024-09-30 | 55.3 K | Northern Trust Corp | 2024-09-30 | 41.4 K | Titleist Asset Management, Llc | 2024-09-30 | 39 K | Vanguard Group Inc | 2024-09-30 | 625.1 K | Cambridge Invest Research Advisors, Inc. | 2024-09-30 | 554.4 K |
Fortress Biotech Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Fortress Biotech insiders, such as employees or executives, is commonly permitted as long as it does not rely on Fortress Biotech's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Fortress Biotech insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Fortress Biotech Outstanding Bonds
Fortress Biotech issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Fortress Biotech uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Fortress bonds can be classified according to their maturity, which is the date when Fortress Biotech has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| FORTUNE BRANDS HOME Corp BondUS34964CAA45 | View | |
| US34964CAE66 Corp BondUS34964CAE66 | View | |
| FBINUS 45 25 MAR 52 Corp BondUS34964CAG15 | View | |
| FBINUS 4 25 MAR 32 Corp BondUS34964CAF32 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| HSBC Holdings PLC Corp BondUS404280DR76 | View | |
| US34960PAD33 Corp BondUS34960PAD33 | View | |
| FORTUNE BRANDS INC Corp BondUS349631AG67 | View |
Pair Trading with Fortress Biotech
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Fortress Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Fortress Biotech will appreciate offsetting losses from the drop in the long position's value.Moving against Fortress Stock
The ability to find closely correlated positions to Fortress Biotech could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fortress Biotech when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fortress Biotech - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fortress Biotech to buy it.
The correlation of Fortress Biotech is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fortress Biotech moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fortress Biotech moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fortress Biotech can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fortress Biotech. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product. To learn how to invest in Fortress Stock, please use our How to Invest in Fortress Biotech guide.You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fortress Biotech. If investors know Fortress will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fortress Biotech listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (27.73) | Revenue Per Share 6.15 | Quarterly Revenue Growth (0.14) | Return On Assets (0.36) | Return On Equity (17.40) |
The market value of Fortress Biotech is measured differently than its book value, which is the value of Fortress that is recorded on the company's balance sheet. Investors also form their own opinion of Fortress Biotech's value that differs from its market value or its book value, called intrinsic value, which is Fortress Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fortress Biotech's market value can be influenced by many factors that don't directly affect Fortress Biotech's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fortress Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine if Fortress Biotech is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fortress Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.